Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasis.

Bowes J, Ashcroft J, Dand N, Jalali-Najafabadi F, Bellou E, Ho P, Marzo-Ortega H, Helliwell PS, Feletar M, Ryan AW, Kane DJ, Korendowych E, Simpson MA, Packham J, McManus R, Brown MA, Smith CH, Barker JN, McHugh N, FitzGerald O, Warren RB, Barton A.

Ann Rheum Dis. 2017 Oct;76(10):1774-1779. doi: 10.1136/annrheumdis-2017-211414. Epub 2017 Aug 18.

2.
3.

Corrigendum: Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Jul 6;6:7741. doi: 10.1038/ncomms8741. No abstract available.

4.

PTPN22 is associated with susceptibility to psoriatic arthritis but not psoriasis: evidence for a further PsA-specific risk locus.

Bowes J, Loehr S, Budu-Aggrey A, Uebe S, Bruce IN, Feletar M, Marzo-Ortega H, Helliwell P, Ryan AW, Kane D, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, Brown MA, Behrens F, Burkhardt H, McHugh N, Huffmeier U, Ho P, Reis A, Barton A.

Ann Rheum Dis. 2015 Oct;74(10):1882-5. doi: 10.1136/annrheumdis-2014-207187. Epub 2015 Apr 28.

5.

Dense genotyping of immune-related susceptibility loci reveals new insights into the genetics of psoriatic arthritis.

Bowes J, Budu-Aggrey A, Huffmeier U, Uebe S, Steel K, Hebert HL, Wallace C, Massey J, Bruce IN, Bluett J, Feletar M, Morgan AW, Marzo-Ortega H, Donohoe G, Morris DW, Helliwell P, Ryan AW, Kane D, Warren RB, Korendowych E, Alenius GM, Giardina E, Packham J, McManus R, FitzGerald O, McHugh N, Brown MA, Ho P, Behrens F, Burkhardt H, Reis A, Barton A.

Nat Commun. 2015 Feb 5;6:6046. doi: 10.1038/ncomms7046. Erratum in: Nat Commun. 2015;6:7741.

6.

Effects of Hylan G-F 20 supplementation on cartilage preservation detected by magnetic resonance imaging in osteoarthritis of the knee: a two-year single-blind clinical trial.

Wang Y, Hall S, Hanna F, Wluka AE, Grant G, Marks P, Feletar M, Cicuttini FM.

BMC Musculoskelet Disord. 2011 Aug 24;12:195. doi: 10.1186/1471-2474-12-195.

7.

Effect of psoriatic arthritis according to the affected categories of the international classification of functioning, disability and health.

Taylor WJ, Mease PJ, Adebajo A, Nash PJ, Feletar M, Gladman DD.

J Rheumatol. 2010 Sep;37(9):1885-91. doi: 10.3899/jrheum.091315. Epub 2010 Jul 1.

PMID:
20595273
8.

Prolonged remission in systemic lupus erythematosus.

Urowitz MB, Feletar M, Bruce IN, Ibañez D, Gladman DD.

J Rheumatol. 2005 Aug;32(8):1467-72.

PMID:
16078321
9.

The clinical assessment of patients with psoriatic arthritis: results of a reliability study of the spondyloarthritis research consortium of Canada.

Gladman DD, Cook RJ, Schentag C, Feletar M, Inman RI, Hitchon C, Karsh J, Klinkhoff AV, Maksymowych WP, Mosher DP, Nair B, Stone MA.

J Rheumatol. 2004 Jun;31(6):1126-31.

PMID:
15170925
10.

Treatment of refractory psoriatic arthritis with infliximab: a 12 month observational study of 16 patients.

Feletar M, Brockbank JE, Schentag CT, Lapp V, Gladman DD.

Ann Rheum Dis. 2004 Feb;63(2):156-61.

11.
12.

Osteoid osteoma: a case for conservative management.

Feletar M, Hall S.

Rheumatology (Oxford). 2002 May;41(5):585-6. No abstract available.

PMID:
12011385
13.

The value of clinical signs in rheumatology.

Feletar M, Littlejohn G.

Aust Fam Physician. 1999 Dec;28(12):1223-7.

PMID:
10650595

Supplemental Content

Loading ...
Support Center